Please try another search
With the proposed sale of Acal BFi, DiscoverIE (LON:DSCV) is taking the final step to exit the Custom Supply business. Gross proceeds of £50m will be used to reduce debt, providing further...
Newmont's (NYSE:NEM) Q321 results were closely in line with our prior forecasts (see Exhibits 1 and 2), albeit with relative outperformance from its Australian operations largely offsetting...
Foresight Solar Fund (LON:FSFL) is the largest solar investor listed in the UK by installed capacity. With power prices more than tripling in 2021, FSFL’s c 25% merchant share of revenues allows...
Foxtons (LON:FOXT) has traded well ytd, with total revenue exceeding £100m and only c £3m short of the £106.9m reported for the whole of FY19. The company has not only benefited from...
Primary Health Properties (LON:PHP) has announced refinancing measures that enhance debt duration and significantly reduce the running cost of debt. Our forecasts for earnings and fully covered...
Ahead of CentralNic's (LON:CNIC) seasonally strongest quarter, it has reported trading for the first nine months of FY21 (9M21) ahead of market expectations. Noting the acceleration of organic growth...
Borussia Dortmund (DE:BVB) has an established track record as one of the most successful football clubs in Europe. This enables it to exploit structural tailwinds, increasing global and multi-media...
Whitbread (LON:WTB) continues to show that the strong get stronger with Premier Inn, much the largest UK hotel chain, materially outperforming the market throughout H1 to August and to date (by 14% in...
Wandisco (LON:WAND), a company that replicates petabyte scale data to the cloud, last week announced the general availability of its LiveData Migrator on Azure (LDMA). While this could be a...
Kazia Therapeutics (ASX:KZA) is an oncology focused drug development company based in Sydney, Australia. In addition to Kazia’s lead programme, paxalisib, a brain-penetrant inhibitor of the...
Deutsche Börse (DE:DB1Gn) (DB1) is a leading European capital markets infrastructure provider with activities across pre-trading, trading and clearing, and post-trade segments. Its diversity...
BioPorto has announced the appointment of Anthony Pare and Neil Goldman as its new CEO and CFO, respectively, with effect from mid-November 2021. In addition, Thomas Magnussen, chairman of the Board...
Private Canadian biotech firm Hyasynth recently announced a US patent award for using yeast to biosynthesize cannabinoids and is the first to sell yeast-derived cannabidiol (CBD) built on this...
GB Group (LON:GBGP) (GBG) confirmed that its Identity business continued to benefit from a number of exceptional volume drivers in H122, resulting in 12.4% y-o-y organic constant currency revenue...
Love Hemp (AQUIS:LIFE) has established a leading presence in the UK CBD market and is looking to replicate this achievement globally. Key to its success will be product development, the introduction...
DiscoverIE's (LON:DSCV) trading update confirmed that performance in H122 was ahead of board expectations, with organic revenue growth of 15% y-o-y and 8% versus the pre-COVID H120. Despite supply...
Centaur Media's (LON:CAU) trading update, issued alongside its capital markets day, indicates good progress in H221 to date, building on the post-pandemic recovery in revenues and margin reported for...